Petros Pharmaceuticals, Inc. (PTPI)
NASDAQ: PTPI · Real-Time Price · USD
0.1195
-0.0006 (-0.50%)
At close: May 12, 2025, 4:00 PM
0.1190
-0.0005 (-0.42%)
After-hours: May 12, 2025, 7:59 PM EDT
Petros Pharmaceuticals Market Cap
Petros Pharmaceuticals has a market cap or net worth of $255.82 thousand as of May 12, 2025. Its market cap has decreased by -94.14% in one year.
Market Cap
255.82K
Enterprise Value
3.93M
1-Year Change
-94.14%
Ranking
Category
Stock Price
$0.12
Market Cap Chart
Since December 2, 2020, Petros Pharmaceuticals's market cap has decreased from $38.73M to $255.82K, a decrease of -99.34%. That is a compound annual growth rate of -67.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 9, 2025 | 257.10K | -93.48% |
| Dec 31, 2024 | 3.94M | 27.11% |
| Dec 29, 2023 | 3.10M | -35.68% |
| Dec 30, 2022 | 4.82M | -92.98% |
| Dec 31, 2021 | 68.71M | 60.87% |
| Dec 31, 2020 | 42.71M | 10.27% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 659.45B |
| Johnson & Johnson | 371.06B |
| UnitedHealth Group | 345.29B |
| AbbVie | 326.55B |
| Novo Nordisk | 297.79B |
| Abbott Laboratories | 231.82B |
| Novartis AG | 214.71B |
| AstraZeneca | 211.14B |